Metropolitan Life Insurance CO Corbus Pharmaceuticals Holdings, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$1.5 - $9.38 $32,329 - $202,167	-21,553 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$4.79 - $8.39 $103,238 - $180,829	21,553 New	21,553 $180,000
Q1 2020 Jul 12, 2023	BUY	$3.44 - $7.21 $74,142 - $155,397	21,553 New	21,553 $112,000
Q1 2020 Mar 30, 2023	BUY	$3.44 - $7.21 $443 - $930	129 Added 0.6%	21,553 $112,000
Q1 2020 May 15, 2020	BUY	$3.44 - $7.21 $443 - $930	129 Added 0.6%	21,553 $113,000
Q4 2019 Jul 12, 2023	BUY	$4.29 - $5.64 $91,908 - $120,831	21,424 New	21,424 $116,000
Q4 2019 Mar 30, 2023	BUY	$4.29 - $5.64 $22,449 - $29,514	5,233 Added 32.32%	21,424 $116,000
Q4 2019 Feb 14, 2020	BUY	$4.29 - $5.64 $22,449 - $29,514	5,233 Added 32.32%	21,424 $117,000
Q3 2019 Jul 12, 2023	BUY	$4.87 - $7.08 $78,850 - $114,632	16,191 New	16,191 $78,000
Q3 2019 Mar 30, 2023	BUY	$4.87 - $7.08 $7,061 - $10,266	1,450 Added 9.84%	16,191 $78,000
Q3 2019 Nov 14, 2019	BUY	$4.87 - $7.08 $7,061 - $10,266	1,450 Added 9.84%	16,191 $79,000
Q2 2019 Jul 12, 2023	BUY	$6.6 - $7.8 $118,522 - $140,072	17,958 New	17,958 $124,000
Q1 2019 Jul 13, 2023	BUY	$5.76 - $8.95 $84,908 - $131,931	14,741 New	14,741 $102,000
Q1 2019 Mar 30, 2023	BUY	$5.76 - $8.95 $84,908 - $131,931	14,741 New	14,741 $102,000
Q1 2019 May 16, 2019	BUY	$5.76 - $8.95 $9,682 - $15,044	1,681 Added 12.87%	14,741 $102,000
Q1 2019 May 15, 2019	SELL	$5.76 - $8.95 $22,538 - $35,021	-3,913 Reduced 23.05%	13,060 $217,000
Q4 2018 Jul 13, 2023	BUY	$5.26 - $7.97 $89,277 - $135,274	16,973 New	16,973 $99,000
Q4 2018 Feb 14, 2019	BUY	$5.26 - $7.97 $69,773 - $105,722	13,265 Added 357.74%	16,973 $99,000
Q3 2018 Jul 13, 2023	BUY	$4.65 - $7.95 $78,924 - $134,935	16,973 New	16,973 $128 Million
Q3 2018 Nov 14, 2018	SELL	$4.65 - $7.95 $61,682 - $105,456	-13,265 Reduced 78.15%	3,708 $28,000
Q1 2018 May 15, 2018	BUY	$5.6 - $9.25 $13,568 - $22,412	2,423 Added 16.65%	16,973 $0
Q4 2017 Feb 15, 2018	SELL	$6.6 - $7.78 $123,664 - $145,773	-18,737 Reduced 56.29%	14,550 $103,000
Q3 2017 Nov 14, 2017	SELL	$5.75 - $7.75 $1,109 - $1,495	-193 Reduced 0.58%	33,287 $238,000
Q2 2017 Aug 14, 2017	BUY	N/A	33,480	33,480 $211,000

Others Institutions Holding CRBP

# of Institutions

Shares Held

38.7K

Call Options Held

Put Options Held

Kingsbury Capital Investment Advisors LLC Evanston, IL

33.7K
Shares

$378,788
0.01% of portfolio
Exane Derivatives

2.65K
Shares

$29,786
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.31K
Shares

$25,986
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Corbus Pharmaceuticals Holdings, Inc.

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.41B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

More about CRBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account